Go Pro

NexGel (NXGL) Competitors

NexGel logo
$0.36 -0.02 (-4.63%)
As of 04:00 PM Eastern

NXGL vs. LUCY, BMRA, CUPR, LUCYW, and NXGLW

Should you buy NexGel stock or one of its competitors? NexGel's main competitors and comparable companies include Innovative Eyewear (LUCY), Biomerica (BMRA), Cuprina Holdings (Cayman) (CUPR), Innovative Eyewear (LUCYW), and NEXGEL (NXGLW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does NexGel compare to Innovative Eyewear?

NexGel (NASDAQ:NXGL) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

NexGel has higher revenue and earnings than Innovative Eyewear. NexGel is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NexGel$11.42M0.29-$3M-$0.40N/A
Innovative Eyewear$2.66M1.68-$7.59M-$1.69N/A

2.2% of NexGel shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 23.4% of NexGel shares are owned by insiders. Comparatively, 1.7% of Innovative Eyewear shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

NexGel currently has a consensus target price of $2.00, indicating a potential upside of 451.88%. Given NexGel's stronger consensus rating and higher possible upside, equities analysts clearly believe NexGel is more favorable than Innovative Eyewear.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NexGel
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Innovative Eyewear
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

NexGel has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.72, suggesting that its stock price is 172% more volatile than the broader market.

In the previous week, NexGel and NexGel both had 1 articles in the media. NexGel's average media sentiment score of 0.00 equaled Innovative Eyewear'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NexGel
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Innovative Eyewear
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

NexGel has a net margin of -28.54% compared to Innovative Eyewear's net margin of -272.42%. NexGel's return on equity of -64.29% beat Innovative Eyewear's return on equity.

Company Net Margins Return on Equity Return on Assets
NexGel-28.54% -64.29% -29.64%
Innovative Eyewear -272.42%-83.37%-76.02%

Summary

NexGel beats Innovative Eyewear on 11 of the 13 factors compared between the two stocks.

How does NexGel compare to Biomerica?

NexGel (NASDAQ:NXGL) and Biomerica (NASDAQ:BMRA) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings.

NexGel has higher revenue and earnings than Biomerica. Biomerica is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NexGel$11.42M0.29-$3M-$0.40N/A
Biomerica$5.31M0.95-$4.97M-$0.89N/A

2.2% of NexGel shares are held by institutional investors. Comparatively, 22.3% of Biomerica shares are held by institutional investors. 23.4% of NexGel shares are held by company insiders. Comparatively, 18.0% of Biomerica shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

NexGel presently has a consensus target price of $2.00, indicating a potential upside of 451.88%. Biomerica has a consensus target price of $9.00, indicating a potential upside of 452.15%. Given Biomerica's higher probable upside, analysts clearly believe Biomerica is more favorable than NexGel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NexGel
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Biomerica
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

NexGel has a net margin of -28.54% compared to Biomerica's net margin of -96.49%. NexGel's return on equity of -64.29% beat Biomerica's return on equity.

Company Net Margins Return on Equity Return on Assets
NexGel-28.54% -64.29% -29.64%
Biomerica -96.49%-98.14%-70.42%

In the previous week, NexGel had 1 more articles in the media than Biomerica. MarketBeat recorded 1 mentions for NexGel and 0 mentions for Biomerica. NexGel's average media sentiment score of 0.00 equaled Biomerica'saverage media sentiment score.

Company Overall Sentiment
NexGel Neutral
Biomerica Neutral

NexGel has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market. Comparatively, Biomerica has a beta of 0.35, suggesting that its share price is 65% less volatile than the broader market.

Summary

NexGel beats Biomerica on 12 of the 15 factors compared between the two stocks.

How does NexGel compare to Cuprina Holdings (Cayman)?

NexGel (NASDAQ:NXGL) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations.

NexGel has higher revenue and earnings than Cuprina Holdings (Cayman).

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NexGel$11.42M0.29-$3M-$0.40N/A
Cuprina Holdings (Cayman)$40K69.92-$3.63MN/AN/A

2.2% of NexGel shares are held by institutional investors. 23.4% of NexGel shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

NexGel has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market. Comparatively, Cuprina Holdings (Cayman) has a beta of -0.35, indicating that its stock price is 135% less volatile than the broader market.

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to NexGel's net margin of -28.54%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat NexGel's return on equity.

Company Net Margins Return on Equity Return on Assets
NexGel-28.54% -64.29% -29.64%
Cuprina Holdings (Cayman) N/A N/A N/A

NexGel currently has a consensus price target of $2.00, suggesting a potential upside of 451.88%. Given NexGel's stronger consensus rating and higher probable upside, analysts plainly believe NexGel is more favorable than Cuprina Holdings (Cayman).

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NexGel
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cuprina Holdings (Cayman)
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, NexGel and NexGel both had 1 articles in the media. NexGel's average media sentiment score of 0.00 beat Cuprina Holdings (Cayman)'s score of -0.45 indicating that NexGel is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NexGel
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cuprina Holdings (Cayman)
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

NexGel beats Cuprina Holdings (Cayman) on 9 of the 13 factors compared between the two stocks.

How does NexGel compare to Innovative Eyewear?

NexGel (NASDAQ:NXGL) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment.

2.2% of NexGel shares are held by institutional investors. 23.4% of NexGel shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, NexGel had 1 more articles in the media than Innovative Eyewear. MarketBeat recorded 1 mentions for NexGel and 0 mentions for Innovative Eyewear. NexGel's average media sentiment score of 0.00 equaled Innovative Eyewear'saverage media sentiment score.

Company Overall Sentiment
NexGel Neutral
Innovative Eyewear Neutral

Innovative Eyewear has a net margin of 0.00% compared to NexGel's net margin of -28.54%. Innovative Eyewear's return on equity of 0.00% beat NexGel's return on equity.

Company Net Margins Return on Equity Return on Assets
NexGel-28.54% -64.29% -29.64%
Innovative Eyewear N/A N/A N/A

Innovative Eyewear has lower revenue, but higher earnings than NexGel.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NexGel$11.42M0.29-$3M-$0.40N/A
Innovative Eyewear$2.98MN/AN/AN/AN/A

NexGel currently has a consensus price target of $2.00, indicating a potential upside of 451.88%. Given NexGel's stronger consensus rating and higher possible upside, equities research analysts plainly believe NexGel is more favorable than Innovative Eyewear.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NexGel
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

NexGel beats Innovative Eyewear on 7 of the 10 factors compared between the two stocks.

How does NexGel compare to NEXGEL?

NEXGEL (NASDAQ:NXGLW) and NexGel (NASDAQ:NXGL) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

2.2% of NexGel shares are held by institutional investors. 23.4% of NexGel shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, NexGel had 1 more articles in the media than NEXGEL. MarketBeat recorded 1 mentions for NexGel and 0 mentions for NEXGEL. NEXGEL's average media sentiment score of 0.00 equaled NexGel'saverage media sentiment score.

Company Overall Sentiment
NEXGEL Neutral
NexGel Neutral

NEXGEL has higher earnings, but lower revenue than NexGel.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$11.27MN/AN/AN/AN/A
NexGel$11.42M0.29-$3M-$0.40N/A

NexGel has a consensus target price of $2.00, indicating a potential upside of 451.88%. Given NexGel's stronger consensus rating and higher possible upside, analysts clearly believe NexGel is more favorable than NEXGEL.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NEXGEL
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
NexGel
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

NEXGEL has a net margin of 0.00% compared to NexGel's net margin of -28.54%. NEXGEL's return on equity of 0.00% beat NexGel's return on equity.

Company Net Margins Return on Equity Return on Assets
NEXGELN/A N/A N/A
NexGel -28.54%-64.29%-29.64%

Summary

NexGel beats NEXGEL on 7 of the 10 factors compared between the two stocks.

Get NexGel News Delivered to You Automatically

Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NXGL vs. The Competition

MetricNexGelHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$3.51M$5.82B$7.02B$12.98B
Dividend YieldN/A1.78%2.58%10.20%
P/E Ratio-0.9120.21210.3420.96
Price / Sales0.2961.03588.7886.31
Price / CashN/A33.5528.8937.42
Price / Book0.606.2111.276.42
Net Income-$3M$147.87M$3.45B$347.03M
7 Day Performance-14.37%3.40%3.56%2.48%
1 Month Performance-30.03%1.66%-0.58%-1.04%
1 Year Performance-86.53%6.26%77.52%23.22%

NexGel Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NXGL
NexGel
2.0702 of 5 stars
$0.36
-4.6%
$2.00
+451.9%
-85.9%$3.51M$11.42MN/A10
LUCY
Innovative Eyewear
0.2926 of 5 stars
$0.71
-3.9%
N/A-63.3%$4.75M$2.66MN/A9
BMRA
Biomerica
1.8789 of 5 stars
$1.62
+5.9%
$9.00
+455.6%
-47.1%$4.73M$5.31MN/A60
CUPR
Cuprina Holdings (Cayman)
0.6642 of 5 stars
$3.58
+20.5%
N/AN/A$2.73M$49.89KN/A14
LUCYW
Innovative Eyewear
N/A$0.05
-18.3%
N/A-20.5%$0.00$2.98MN/A9

Related Companies and Tools


This page (NASDAQ:NXGL) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners